Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death The ALPHEE Study

Kowey P. R., Crijns H. J. G. M., Aliot E. M., Capucci A., Kulakowski P., Radzik D., ...Daha Fazla

CIRCULATION, cilt.124, sa.24, ss.2649-2667, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 124 Sayı: 24
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1161/circulationaha.111.072561
  • Dergi Adı: CIRCULATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2649-2667
  • Anahtar Kelimeler: celivarone, implanted cardioverter defibrillators, sudden death, ventricular arrhythmia, ANTIARRHYTHMIC-DRUGS, ATRIAL-FIBRILLATION, IN-VIVO, SSR149744C, SOTALOL, SHOCKS, TRIAL
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Background-Celivarone is a new antiarrhythmic agent developed for the treatment of ventricular arrhythmias. This study investigated the efficacy and safety of celivarone in preventing implantable cardioverter-defibrillator (ICD) interventions or death.